Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Preparing Stability Study Reports for Regulatory Submissions – V 2.0

Posted on By

Gel Manufacturing: SOP for Preparing Stability Study Reports for Regulatory Submissions – V 2.0

Standard Operating Procedure for Preparing Stability Study Reports for Regulatory Submissions in Gel Manufacturing


Department Gel Manufacturing
SOP No. SOP/GM/107/2025
Supersedes SOP/GM/107/2022
Page No. Page 1 of 13
Issue Date 02/06/2025
Effective Date 04/06/2025
Review Date 02/06/2027

1. Purpose

To describe the procedure for preparing comprehensive stability study reports for gel formulations intended for regulatory submission, including structure, data presentation, summary interpretation, and approval workflow.

2. Scope

This procedure applies to all stability studies conducted on gel drug products manufactured at

this facility, including new product development, validation batches, and post-approval changes requiring submission to regulatory authorities.

3. Responsibilities

  • Stability Coordinator: Compiles study data and drafts the initial report.
  • QC Analyst: Provides raw data and analytical results.
  • QA Executive: Reviews data integrity, accuracy, and compliance before submission.
  • Regulatory Affairs: Finalizes the report format and aligns content with regulatory guidelines.
See also  Gel Manufacturing: SOP for Cleaning of Sampling Booth and Tools - V 2.0

4. Accountability

Manager – Quality Assurance is accountable for ensuring that all stability study reports are accurate, complete, and submitted within regulatory timelines.

5. Procedure

5.1 Collection of Data

  1. Obtain approved stability protocol and ensure tests are performed per the schedule outlined in ICH Q1A(R2) guidelines.
  2. Collect data for all prescribed storage conditions (e.g., 25°C/60%RH, 30°C/65%RH, 40°C/75%RH).
  3. Compile test parameters including appearance, pH, assay, degradation products, viscosity, microbial limits, and preservative efficacy.

5.2 Report Structure

The report shall be structured as follows:

  1. Cover Page: Title, product name, batch number, study type, study period.
  2. Table of Contents
  3. Executive Summary: Objectives and conclusions of the study.
  4. Introduction: Background and rationale.
  5. Methodology: Storage conditions, sampling intervals, test methods.
  6. Results: Tabulated and graphical presentation.
  7. Discussion: Data interpretation, trends, and compliance.
  8. Conclusion: Shelf-life proposal and regulatory impact.
  9. Appendices: Raw data, chromatograms, certificates of analysis (COAs).
See also  Gel Manufacturing: SOP for Equipment Swab Testing for Cleaning Effectiveness - V 2.0

5.3 Data Presentation

  1. Present results in a tabular format with time points, means, standard deviations, and specification limits.
  2. Include graphical trend charts to highlight assay stability, impurity growth, and viscosity shifts.
  3. Use color-coded formats for highlighting OOS/OOT results, if any.

5.4 Review and Approval

  1. Initial draft reviewed by QC Lead and QA Executive for accuracy and completeness.
  2. Regulatory Affairs ensures alignment with agency submission requirements (e.g., CTD format).
  3. Final report to be signed by QA Head and submitted as part of product dossier or variation filing.

5.5 Archiving and Retention

  1. Stability reports shall be stored in both hardcopy and electronic formats.
  2. Electronic copies shall be uploaded to the Document Management System (DMS).
  3. Retention period: Minimum of 5 years or as per regulatory requirement.

6. Abbreviations

  • ICH: International Council for Harmonisation
  • CTD: Common Technical Document
  • COA: Certificate of Analysis
  • QA: Quality Assurance
  • QC: Quality Control
See also  Gel Manufacturing: SOP for Weighing Raw Materials for Gel Formulations - V 2.0

7. Documents

  1. Stability Study Protocol
  2. Stability Study Report – Annexure-1
  3. Certificates of Analysis
  4. Analytical Raw Data

8. References

  • ICH Q1A(R2): Stability Testing of New Drug Substances and Products
  • ICH Q1E: Evaluation for Stability Data
  • WHO TRS 1010 Annex 2: Stability Testing of Finished Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Stability Study Report Format

Product Name
Batch Number
Manufacturing Date
Study Period
Storage Conditions 25°C/60%RH, 30°C/65%RH, 40°C/75%RH
Study Type Long-term / Accelerated
Stability Parameters Tested
Results Summary Attach charts/tables
Conclusion
Prepared By
Reviewed By
Approved By

Revision History

Revision Date Revision No. Change Description Reason Approved By
15/03/2022 1.0 Initial issue New SOP QA Head
02/06/2025 2.0 Updated template, included CTD requirements Annual review QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Creams: SOP for Establishing Quality Metrics in Cream Manufacturing – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Supplier Qualification of Raw Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version